gut.bmj

Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results

Correspondence to Dr Tim Wyant, Takeda Pharmaceuticals International Co, 40 Landsdowne St, Cambridge, MA 02139, USA; Tim.Wyant{at}takeda.com Design In this randomised, double-blind, placebo-controlled ...
gut.bmj

Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis

Objective In patients with pancreatitis, early persisting organ failure is believed to be the most important cause of mortality. This study investigates the relation between the timing (onset and ...
Gut

Epigenetic therapies in hepatocellular carcinoma: emerging clinical tools and applications

Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide, largely due to the limited efficacy of ...
gut.bmj

Modulation of human dendritic cell phenotype and function by probiotic bacteria

2 Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy 3 Department of Pharmaceutical Sciences, University of Bologna, Bologna, Italy 4 Department of ...
gut.bmj

Gastritis staging in clinical practice: the OLGA staging system

Background: The available classifications of gastritis are inconsistently used, possibly because none provides immediate prognostic/therapeutic information to clinicians. As histology reporting of ...
gut.bmj

An Assessment of Prednisone, Salazopyrin, and Topical Hydrocortisone Hemisuccinate Used as Out-patient Treatment for Ulcerative Colitis

Two consecutive trials of out-patient treatment for mild cases of active ulcerative colitis are described. In the first trial oral prednisone gave significantly better results than a placebo. In the ...
gut.bmj

Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy

Objective To evaluate the efficacy and tolerability of replacing tetracycline with amoxicillin in bismuth quadruple therapy. Results Two hundred and fifteen subjects were randomised. Metronidazole and ...
gut.bmj

Progressive familial intrahepatic cholestasis types 1, 2, and 3

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
gut.bmj

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

ProfessorDr P Rutgeerts, Internal Medicine, Department of Gastroenterology, Herestraat 49, B-3000 Leuven, Belgium; Paul.Rutgeerts{at}uz.kuleuven.ac.be Background and aims: This study evaluates the ...
gut.bmj

Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies

Objectives: To derive age and sex specific estimates of transition rates from advanced adenomas to colorectal cancer by combining data of a nationwide screening colonoscopy registry and national data ...
gut.bmj

Guidelines for colorectal cancer screening in high risk groups

The British Society of Gastroenterology (BSG) and the Association of Coloproctolgy for Great Britain and Ireland (ACPGBI) commissioned these guidelines. The aim is to provide guidance on the ...
Gut

AI-empowered human microbiome research

Recent advances in high-throughput microbiome profiling have generated expansive data sets that offer unprecedented ...